Secondary bile acids and the biliary epithelia: The good and the bad.

World J Gastroenterol

Hepatology Unit, Policlinico Tor Vergata, Rome 00133, Italy.

Published: January 2023


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The biliary tract has been considered for several decades a passive system just leading the hepatic bile to the intestine. Nowadays several researches demonstrated an important role of biliary epithelia ( cholangiocytes) in bile formation. The study of biliary processes therefore maintains a continuous interest since the possible important implications regarding chronic cholestatic human diseases, such as primary biliary cholangitis or primary sclerosing cholangitis. Bile acids (BAs), produced by the liver, are the most represented organic molecules in bile. The physiologic importance of BAs was initially attributed to their behavior as natural detergents but several studies now demonstrate they are also important signaling molecules. In this minireview the effect of BAs on the biliary epithelia are reported focusing in particular on secondary (deriving by bacterial manipulation of primary molecules) ones. This class of BAs is demonstrated to have relevant biological effects, ranging from toxic to therapeutic ones. In this family ursodeoxycholic and lithocholic acid present the most interesting features. The molecular mechanisms linking ursodeoxycholic acid to its beneficial effects on the biliary tract are discussed in details as well as data on the processes leading to lithocholic damage. These findings suggest that expansion of research in the field of BAs/cholangiocytes interaction may increase our understanding of cholestatic diseases and should be helpful in designing more effective therapies for biliary disorders.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846939PMC
http://dx.doi.org/10.3748/wjg.v29.i2.357DOI Listing

Publication Analysis

Top Keywords

biliary epithelia
12
bile acids
8
biliary
8
biliary tract
8
secondary bile
4
acids biliary
4
epithelia good
4
good bad
4
bad biliary
4
tract considered
4

Similar Publications

Directed differentiation of human pluripotent stem cells into pancreatobiliary co-progenitor-like population.

Biochem Biophys Res Commun

August 2025

Department of Developmental and Regenerative Biology, iORGANtech Limited Company (Suzhou), Suzhou, 215000, China; Tianjin Key Laboratory of Early Druggability Evaluation of Innovative Drugs and Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tia

Progress in uncovering the causes of extrahepatic biliary diseases and developing new therapies has been constrained by the inaccessibility of donor tissue and a lack of experimental models. Although hepatic, intrahepatic biliary, and pancreatic 2D/3D models have been successfully established from pluripotent stem cells (PSCs), in vitro generation of extrahepatic biliary cells remains a major challenge, due to the absence of developmental cues. Here we report a de novo method for directed differentiation of human PSCs (both embryonic and induced) into pancreato-biliary progenitors-like cells (PBPLCs).

View Article and Find Full Text PDF

Introduction: Distal cholangiocarcinoma is a malignant tumor that arises from the epithelial cells of the bile duct. Several risk factors associated with cholangiocarcinoma have been identified. Multiple distal cholangiocarcinomas may occur in patients with several risk factors for cholangiocarcinoma.

View Article and Find Full Text PDF

Aims: To characterize "neoplastic ductal plate malformation pattern (N-DPMP)" of intrahepatic cholangiocarcinoma (iCCA) and to evaluate whether or not von Meyenburg complexes (VMCs) and VMC-mimics characterized by dysplasia/carcinoma in situ were related to the development of iCCA.

Materials And Methods: N-DPMP composed of low-grade neoplastic biliary epithelia and showing ductal plate malformation (DPM) features, VMCs, and VMC-mimics were surveyed in 144 small duct-type (SD)-iCCA cases and 47 large duct-type (LD)-iCCA cases. Genetic alterations were examined by direct sequencing and immunohistochemistry.

View Article and Find Full Text PDF

IgG4-Related Cholangitis.

Semin Liver Dis

May 2025

Department of Gastroenterology and Hepatology, Tytgat Institute for Liver and Intestinal Research, AGEM, Amsterdam University Medical Center, Amsterdam, The Netherlands.

IgG4-related cholangitis (IRC) is a rare fibroinflammatory disease of the biliary tree and liver and presents the major hepatobiliary manifestation of IgG4-related systemic disease (IgG4-RD). IRC also includes the IgG4-related inflammatory pseudotumor of the liver and IgG4-related cholecystitis. IRC mimics other cholangiopathies such as primary sclerosing cholangitis or cholangiocarcinoma.

View Article and Find Full Text PDF
Article Synopsis
  • A study of 121 cases of small duct-type intrahepatic cholangiocarcinoma (small duct-iCCA) identified intraductal polypoid neoplasms in 8 cases (6.6%), which showed growth patterns adjacent to mass-forming tumors.
  • These polypoid neoplasms were found to have histological and immunohistochemical similarities to the primary tumors, indicating a shared biliary subtype and reflecting the cancerization of ductal tissues.
  • A comparison with intraductal papillary neoplasm of the bile duct (IPNB) revealed differences, as IPNBs often presented non-invasive characteristics, suggesting that intraductal polypoid neoplasms should
View Article and Find Full Text PDF